Responses
Clinical and epidemiological research
Extended report
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
Compose a Response to This Article
Other responses
No responses have been published for this article.